aid: candel-therapeutics
name: Candel Therapeutics
description: 'Candel Therapeutics, Inc. (Nasdaq: CADL) is a clinical-stage biopharmaceutical
  company headquartered in Needham, Massachusetts, developing off-the-shelf multimodal
  viral immunotherapies for solid tumors. Founded as Advantagene, the company advances
  two engineered viral platforms: aglatimagene besadenovec (CAN-2409), a replication-defective
  adenovirus delivered intratumorally alongside a prodrug to trigger immunogenic cell
  death, and linoserpaturev (CAN-3110), a replication-competent oncolytic herpes simplex
  virus. Its clinical programs span prostate cancer, non-small cell lung cancer, pancreatic
  cancer and recurrent high-grade glioma. Candel is a therapeutics developer, not a
  software vendor: it operates no developer program, publishes no public API, SDK or
  machine-readable specification, and its only credentialed surface is a clinical-trial
  investigator portal.'
url: https://raw.githubusercontent.com/api-evangelist/candel-therapeutics/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-09-09'
modified: '2026-09-09'
image: https://candeltx.com/hubfs/logo-main-nav-1.svg
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Immunotherapy
- Oncology
- Life Sciences
- Clinical Trials
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://candeltx.com/
- type: About
  url: https://candeltx.com/about
- type: Blog
  url: https://candeltx.com/blog
- type: BlogRSS
  url: https://candeltx.com/blog/rss.xml
- type: Support
  url: https://candeltx.com/contact
- type: PrivacyPolicy
  url: https://candeltx.com/privacy-policy
- type: InvestorRelations
  url: https://ir.candeltx.com/
- type: DomainSecurity
  url: security/candel-therapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/candel-therapeutics-llms.txt
x-enrichment:
  date: '2026-09-09'
  status: minimal
  artifacts_added: 5
  pass: local-v3
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Candel Therapeutics is a clinical-stage biopharmaceutical developer whose
    only credentialed surface is a HubSpot-hosted clinical-trial investigator login;
    every contract-discovery path on candeltx.com returns a real 404 and the company
    publishes no developer portal, API reference or machine-readable specification.
  evidence:
  - url: https://candeltx.com/openapi.json
    status: 404
  - url: https://candeltx.com/.well-known/api-catalog
    status: 404
  - url: https://candeltx.com/sitemap.xml
    status: 200
  - url: https://candeltx.com/investigator-login
    status: 200
  checked: '2026-09-09'